« Previous
Next »
European Journal of Cancer
Volume 45, Issue 6
, Pages 1028-1041
, April 2009
Long-term survival expectations of cancer patients in Europe in 2000–2002
References
- UK Department of Health. The NHS cancer plan: a plan for investment, a plan for reform. <http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4009609>; 2000 [accessed 25.11.07].
- . The Calman–Hine report: a personal retrospective on the UK’s first comprehensive policy on cancer services. Lancet Oncol. 2006;7:336–346
- Berrino F, Capocaccia R, Coleman MP, et al., editors. Survival of cancer patients in Europe. The EUROCARE-3 study. Ann Oncol 2003;14(Suppl.):v9–155.
- Survival of eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study. Lancet Oncol. 2007;8:773–783
- . An alternative approach to monitoring cancer patient survival. Cancer. 1996;78:2004–2010
- . Up-to-date survival curves of patients with cancer by period analysis. J Clin Oncol. 2002;20:826–832
- . Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol. 2002;31:456–462
- . Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish Cancer Registry data. Eur J Cancer. 2004;40:1361–1372
- . Period analysis for ‘up-to-date’ cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer. 2004;40:326–335
- Recent cancer survival in Europe: a 2000–02 period analysis. Lancet Oncol. 2007;8:784–796
- . The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6:101–121
- . The relative survival rate. Cancer. 1995;76:1687–1688
- . Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics. 1982;39:933–942
- SEER*Stat Release 6.3.6. <http://seer.cancer.gov/seerstat/> [accessed 25.11.07].
- . Standard cancer population for estimating age standardized survival ratios. Eur J Cancer. 2004;40:2307–2316
- The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis. Eur J Cancer. 2009;45:909–930
- Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer. 2001;37:1659–1667
- EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol. 2003;14(Suppl. 5):v128–v149
- European health systems and cancer care. Ann Oncol. 2003;14(Suppl. 5):v41–v60
- . Does the UK really have an effective cancer plan?. Lancet Oncol. 2007;8:747
- . Unchanged survival of gastric cancer in the southeastern Netherlands since 1982: result of differential trends in incidence according to Laurén type and subsite. Int J Cancer. 1999;84:28–32
- . Is Helicobacter pylori infection a necessary condition for non-cardia gastric cancer?. Am J Epidemiol. 2004;159:252–258
- Helicobacter pylori infection in Eastern Europe: seroprevalence in the Polish population of Lower Silesia. Am J Gastroenterol. 1996;91:2513–2515
- . Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol. 2005;16:767–772
- . Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer. 2007;43:2179–2193
- . The global smoking epidemic: a history and status report. Clin Lung Cancer. 2004;5:371–376
- . Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer. 2006;119:2417–2422
- Breast cancer mortality patterns and time trends in 10 new EU member states: mortality declining in young women, but still increasing in the elderly. Int J Cancer. 2004;112:1056–1062
- . Self-reported prostate cancer screening in Austria. J Med Screen. 2006;13:148–151
- The changing evolution of renal tumours: a single center experience over a two-decade period. Eur Urol. 2004;45:490–493
- . Non-Hodgkin lymphoma: an update. Lancet Oncol. 2004;5:341–353
- CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006;7:379–391
- . Very long-term survival rates of patients with cancer. J Clin Oncol. 2002;20:4405–4409
- . EUROCARE-4 studies bring new data on cancer survival. Lancet Oncol. 2007;8:752–753
PII: S0959-8049(08)00910-6
doi: 10.1016/j.ejca.2008.11.005
© 2008 Elsevier Ltd. All rights reserved.
« Previous
Next »
European Journal of Cancer
Volume 45, Issue 6
, Pages 1028-1041
, April 2009
